490 related articles for article (PubMed ID: 19321880)
1. APOE alleles in Parkinson disease and their relationship to cognitive decline: a population-based, longitudinal study.
Kurz MW; Dekomien G; Nilsen OB; Larsen JP; Aarsland D; Alves G
J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):166-70. PubMed ID: 19321880
[TBL] [Abstract][Full Text] [Related]
2. Distribution of APOE genotypes in a memory clinic cohort.
van der Flier WM; Pijnenburg YA; Schoonenboom SN; Dik MG; Blankenstein MA; Scheltens P
Dement Geriatr Cogn Disord; 2008; 25(5):433-8. PubMed ID: 18401171
[TBL] [Abstract][Full Text] [Related]
3. APOE-related mortality: effect of dementia, cardiovascular disease and gender.
Rosvall L; Rizzuto D; Wang HX; Winblad B; Graff C; Fratiglioni L
Neurobiol Aging; 2009 Oct; 30(10):1545-51. PubMed ID: 18237822
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E gene polymorphism, total plasma cholesterol level, and Parkinson disease dementia.
Jasinska-Myga B; Opala G; Goetz CG; Tustanowski J; Ochudlo S; Gorzkowska A; Tyrpa J
Arch Neurol; 2007 Feb; 64(2):261-5. PubMed ID: 17296843
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.
Orsitto G; Seripa D; Panza F; Franceschi M; Cascavilla L; Placentino G; Matera MG; Paris F; Capurso C; Solfrizzi V; Dallapiccola B; Pilotto A
Dement Geriatr Cogn Disord; 2007; 23(5):327-33. PubMed ID: 17374951
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E polymorphism and clinical disease phenotypes in Arab patients with schizophrenia.
Akanji AO; Ohaeri JU; Al-Shammri SN; Fatania HR
Neuropsychobiology; 2009; 60(2):67-72. PubMed ID: 19752580
[TBL] [Abstract][Full Text] [Related]
7. Relationship between severity of coronary artery disease and apolipoprotein E gene polymorphism.
Arslan Ince FD; Atay A; Köseoğlu M; Yeşil M; Deveci E
Anadolu Kardiyol Derg; 2010 Jun; 10(3):202-8. PubMed ID: 20538553
[TBL] [Abstract][Full Text] [Related]
8. APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.
Martins CA; Oulhaj A; de Jager CA; Williams JH
Neurology; 2005 Dec; 65(12):1888-93. PubMed ID: 16380608
[TBL] [Abstract][Full Text] [Related]
9. [Apolipoprotein E genotypes in patients investigated for dementia].
Johannsen P; Jakobsen JK; Jørgensen AL
Ugeskr Laeger; 1997 Sep; 159(38):5658-61. PubMed ID: 9340872
[TBL] [Abstract][Full Text] [Related]
10. The effect of MAPT H1 and APOE ε4 on transition from mild cognitive impairment to dementia.
Samaranch L; Cervantes S; Barabash A; Alonso A; Cabranes JA; Lamet I; Ancín I; Lorenzo E; Martínez-Lage P; Marcos A; Clarimón J; Alcolea D; Lleó A; Blesa R; Gómez-Isla T; Pastor P
J Alzheimers Dis; 2010; 22(4):1065-71. PubMed ID: 20930301
[TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset.
Parsian A; Racette B; Goldsmith LJ; Perlmutter JS
Genomics; 2002 Mar; 79(3):458-61. PubMed ID: 11863377
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein E gene polymorphism and the risk of cervical myelopathy in patients with chronic spinal cord compression.
Setzer M; Hermann E; Seifert V; Marquardt G
Spine (Phila Pa 1976); 2008 Mar; 33(5):497-502. PubMed ID: 18317192
[TBL] [Abstract][Full Text] [Related]
13. Antibodies against oxidized LDL and apolipoprotein E polymorphism in demented patients.
Bednarska-Makaruk M; Rodo M; Graban A; Lojkowska W; Bochyńska A; Ryglewicz D; Wehr H
J Neurol Sci; 2009 Aug; 283(1-2):137-8. PubMed ID: 19303604
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E, cardiovascular disease and cognitive function in aging women.
Kang JH; Logroscino G; De Vivo I; Hunter D; Grodstein F
Neurobiol Aging; 2005 Apr; 26(4):475-84. PubMed ID: 15653176
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E polymorphisms in patients with primary open-angle glaucoma.
Zetterberg M; Tasa G; Palmér MS; Juronen E; Teesalu P; Blennow K; Zetterberg H
Am J Ophthalmol; 2007 Jun; 143(6):1059-60. PubMed ID: 17524782
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy.
van der Walt A; Stankovich J; Bahlo M; Taylor BV; van der Mei IA; Foote SJ; Kilpatrick TJ; Rubio JP; Butzkueven H
Neurology; 2009 Sep; 73(13):1018-25. PubMed ID: 19786693
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypes.
Zareparsi S; Kaye J; Camicioli R; Grimslid H; Oken B; Litt M; Nutt J; Bird T; Schellenberg G; Payami H
Ann Neurol; 1997 Oct; 42(4):655-8. PubMed ID: 9382478
[TBL] [Abstract][Full Text] [Related]
18. The missing ApoE allele.
Seripa D; Matera MG; Daniele A; Bizzarro A; Rinaldi M; Gravina C; Bisceglia L; Corbo RM; Panza F; Solfrizzi V; Fazio VM; Forno GD; Masullo C; Dallapiccola B; Pilotto A
Ann Hum Genet; 2007 Jul; 71(Pt 4):496-500. PubMed ID: 17244188
[TBL] [Abstract][Full Text] [Related]
19. Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia.
Pankratz N; Byder L; Halter C; Rudolph A; Shults CW; Conneally PM; Foroud T; Nichols WC
Mov Disord; 2006 Jan; 21(1):45-9. PubMed ID: 16116614
[TBL] [Abstract][Full Text] [Related]
20. Plasma levels of apolipoprotein E and cognitive function in old age.
Mooijaart SP; van Vliet P; van Heemst D; Rensen PC; Berbée JF; Jolles J; de Craen AJ; Westendorp RG
Ann N Y Acad Sci; 2007 Apr; 1100():148-61. PubMed ID: 17460173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]